Zi‐Ning Lei
Impact in
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
- Cancer Research top 5%
Papers in
- Oncology 53
- Drug Transport and Resistance Mechanisms 49
- Metal complexes synthesis and properties 7
-
- Cancer therapeutics and mechanisms 26
- RNA Interference and Gene Delivery 6
- Co-authors
- Zhe‐Sheng Chen (68 shared papers)Qiu‐Xu Teng (37 shared papers)Jing‐Quan Wang (37 shared papers)Chao‐Yun Cai (22 shared papers)Leli Zeng (10 shared papers)Yuqi Yang (21 shared papers)Dong‐Hua Yang (20 shared papers)Pranav Gupta (17 shared papers)
- Journals
- Frontiers in Cell and Developmental Biology (6 papers)Frontiers in Pharmacology (6 papers)Cancer Letters (5 papers)Frontiers in Oncology (5 papers)Biochemical Pharmacology (4 papers)
- Partner nations
- United StatesChinaPakistan
In The Last Decade
Zi‐Ning Lei
73 papers receiving 2.3k citations
Zi‐Ning Lei's Hit Papers
Peers
Comparison fields: 5 of 109
- Oncology 1.2k
- Cancer Research 267
- Molecular Biology 1.2k
- Infectious Diseases 292
- Pediatrics, Perinatology and Child Health 193
Countries citing papers authored by Zi‐Ning Lei
This map shows the geographic impact of Zi‐Ning Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zi‐Ning Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zi‐Ning Lei more than expected).
Fields of papers citing papers by Zi‐Ning Lei
This network shows the impact of papers produced by Zi‐Ning Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zi‐Ning Lei. The network helps show where Zi‐Ning Lei may publish in the future.
Co-authors
The 25 scholars most cited alongside Zi‐Ning Lei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Understanding and targeting resistance mechanisms in cancer Hit paper breakdown → | 2023 | 201 |
| 2 | Signaling pathways and therapeutic interventions in gastric cancer Hit paper breakdown → | 2022 | 191 |
| 3 | 2021 | 108 | |
| 4 | 2018 | 96 | |
| 5 | 2018 | 92 | |
| 6 | 2020 | 71 | |
| 7 | 2018 | 64 | |
| 8 | 2019 | 60 | |
| 9 | 2019 | 57 | |
| 10 | 2018 | 54 | |
| 11 | 2018 | 53 | |
| 12 | 2018 | 50 | |
| 13 | 2020 | 49 | |
| 14 | 2018 | 47 | |
| 15 | 2019 | 43 | |
| 16 | 2020 | 41 | |
| 17 | 2018 | 40 | |
| 18 | 2021 | 40 | |
| 19 | 2020 | 40 | |
| 20 | 2020 | 37 |
About Zi‐Ning Lei
Zi‐Ning Lei is a scholar working on Oncology, Molecular Biology, Infectious Diseases, Pediatrics, Perinatology and Child Health and Surgery, having authored 73 papers that have together received 2.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (49 papers), Cancer therapeutics and mechanisms (26 papers), HIV/AIDS drug development and treatment (16 papers), Pharmacological Effects and Toxicity Studies (10 papers), Metal complexes synthesis and properties (7 papers), RNA Interference and Gene Delivery (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Trace Elements in Health (4 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (267 citations), Molecular Biology (1.2k citations), Infectious Diseases (292 citations) and Pediatrics, Perinatology and Child Health (193 citations). Zi‐Ning Lei has collaborated with scholars based in United States, China and Pakistan. Frequent co-authors include Zhe‐Sheng Chen, Qiu‐Xu Teng, Jing‐Quan Wang, Chao‐Yun Cai, Leli Zeng, Yuqi Yang, Dong‐Hua Yang, Pranav Gupta, Zhuo‐Xun Wu and Yihang Pan. Their work appears in journals such as Frontiers in Cell and Developmental Biology, Frontiers in Pharmacology, Cancer Letters, Frontiers in Oncology and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.